Search Results

You are looking at 71 - 80 of 714 items for :

  • All content x
Clear All
Open access

Anru Wang, Xueqin Yan, Cai Zhang, Caiqi Du, Wenjun Long, Di Zhan, and Xiaoping Luo

body composition or lipid and glucose metabolism (e.g., the use of thyroid medication, thiazolidinediones or metformin) were excluded. All anthropometric and biochemical measures were recorded at baseline and after 6 months of the intervention

Open access

Adrian F Daly, Liliya Rostomyan, Daniela Betea, Jean-François Bonneville, Chiara Villa, Natalia S Pellegata, Beatrice Waser, Jean-Claude Reubi, Catherine Waeber Stephan, Emanuel Christ, and Albert Beckers

with worsening of glucose metabolism. This is an established feature of pasireotide treatment in preclinical and clinical studies of acromegaly ( 44 , 45 ). We noted that both cases developed marked elevations in HbA1c and this required multi

Open access

Xiangyu Gao, Wanwan Sun, Yi Wang, Yawen Zhang, Rumei Li, Jinya Huang, and Yehong Yang

of diabetic patients in a certain region might lead to bias. Furthermore, few studies have addressed the correlation between clinical biochemical features such as lipid metabolism, liver and kidney function, and islet autoimmunity in patients with T2

Open access

Johan Verhelst, Anders F Mattsson, Cecilia Camacho-Hübner, Anton Luger, and Roger Abs

waist decreased significantly at Y1 (80.3 vs 77.4%; P  < 0.001), whereas impaired glucose metabolism increased (17.1 vs 23.3%; P  < 0.001) as well as unfavourable HDL (48.2 vs 50.9%; P  = 0.011). No change was observed for blood pressure and

Open access

Line K Johnson, Kirsten B Holven, Njord Nordstrand, Jan R Mellembakken, Tom Tanbo, and Jøran Hjelmesæth

, total (g) 17.0 85.0  in fruit/vegetables (g) 17.0 13.0  in LMR (g) 72.0  (E %) 6.2 32 Added sugar (g) 1.3 77  (E%) 0.5 29 Fibre (g) 34.4 45.5 Outcomes The main outcomes were the 8-week changes in blood lipids, glucose metabolism, BP and uric acid

Open access

Zeeshan Javed, Maria Papageorgiou, Leigh A Madden, Alan S Rigby, Eric S Kilpatrick, Stephen L Atkin, and Thozhukat Sathyapalan

.clinicaltrials.gov (NCT03008551) and conducted in the Academic Diabetes, Endocrinology and Metabolism Research Centre at Hull Royal Infirmary. All participants gave their informed consent in writing. Inclusion/exclusion criteria and study procedures have been explained

Open access

Qiuli Liu, Lin-ang Wang, Jian Su, Dali Tong, Weihua Lan, Luofu Wang, Gaolei Liu, Jun Zhang, Victor Wei Zhang, Dianzheng Zhang, Rongrong Chen, Qingyi Zhu, and Jun Jiang

Introduction Congenital adrenal hyperplasia (CAH) is one of the most severe disorders of metabolism with an overall incidence of approximately 1:15,000 worldwide ( 1 ). CAH encompasses a group of enzymatic deficiencies of cortisol synthesis

Open access

Flavia Letícia Martins Peçanha, Reinaldo Sousa dos Santos, and Wagner Seixas da-Silva

Introduction Thyroid hormones exert important effects on basal and adaptive metabolism ( 1 ). Although several studies have shown that triiodothyronine (T 3 ) may regulate glucose uptake and oxygen consumption ( 2 , 3 , 4 , 5 , 6 , 7 , 8

Open access

Aneta Gawlik, Michael Shmoish, Michaela F Hartmann, Stefan A Wudy, Zbigniew Olczak, Katarzyna Gruszczynska, and Ze’ev Hochberg

there is possibility of multiple diagnoses or before starting therapy with potentially hepatotoxic medications’ ( 8 ). The consequences of obesity-related NAFLD on liver metabolism are insufficiently understood ( 8 ). As steroid hormones are partially

Open access

Agnieszka Adamska, Aleksandra Maria Polak, Anna Krentowska, Agnieszka Łebkowska, Justyna Hryniewicka, Monika Leśniewska, and Irina Kowalska

regulation of lipid and carbohydrate metabolism ( 11 ). In an experimental study, Meex et al . showed that fetuin-B impaired insulin action in myotubes and hepatocytes and caused glucose intolerance in mice, whereas knockdown of this protein in obese mice